Trial intelligence / Profile preview

Intravesical dimethyl sulfoxide solution for bladder pain syndrome/interstitial cystitis

CTR20160360Phase 2Completed

Sponsor
Beijing Kawei Biopharmaceutical Technology
Start
Aug 2016
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of Dimethyl sulfoxide in Interstitial Cystitis-Bladder Pain Syndrome (IC/BPS), sponsored by Beijing Kawei Biopharmaceutical Technology. Started Aug 2016; status: completed.

02

Drugs

Dimethyl sulfoxide
03

Conditions

Interstitial Cystitis-Bladder Pain Syndrome (IC/BPS)

Beyond the preview

Go deeper on CTR20160360.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on CTR20160360.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call